Optomed has been rallying upwards again today 
+10% and we’re knocking on the door of the €7 milestone… The last time Optomed was over a €7 stock was in February 2022 
20 Likes
Even at the current price, next year’s EV/Sales multiple is 5, so it’s certainly not overpriced yet.
Edit: Foreign investors are only now starting to get interested, as there’s more trading volume again. Waiting for deal news. It could come from the US and China 
8 Likes
The horror decreased at least a little today due to a small bounce 
1 Like
I wouldn’t have believed I’d hit the bottom so nicely when I opened a position in this company on Monday. It looks like the whole solar energy sector is skyrocketing today anyway; did the market remember that these need to be built quite extensively in the future?
9 Likes
Novo Nordisk’s headquarters was smoking a bit.
6 Likes
Fluence Energy today +10% without news and has risen over 20% in about a week
The timing of starting the thread was spot on (white cross) and a couple of buy batches have been picked up into the portfolio, white dots on the chart . The trend turned just while I was looking into it, and the buys were then made into a rising price.
I have to blow my own 
horn when the timing hits the mark for once - at least for now 
Edit: found the reason too
https://seekingalpha.com/news/4109493-solar-shares-surge-as-china-plans-measures-against-price-war
20 Likes
Looks like JPow and the Fed minutes contained something nasty again, as I finally get to my computer and the charts are drilling red toward the center of the earth…? Inflation boogeyman a concern again?
Well, on the other hand, it doesn’t really matter; the whole market lives or dies today based on NVIDIA’s earnings… 
8 Likes
My own quick thoughts on the market:
The Homebuilders sector started to decline when estimated sales (at 17:00) missed expectations at 4.14M, vs. expectation of 4.21M.
The Fed minutes (at 21:00) were, as usual, old news; they noted the persistence of inflation as a disappointment, hinted at rate hikes if necessary, and the “higher for longer” mantra remains strong. Some members would like to keep long-term rates higher for longer. The latest and softer April inflation data had not yet been released before the meeting.
Many are/were expecting a test of new ES/SPX highs, which hasn’t happened yet. The decline began to accelerate for the reasons mentioned above and, from a technical perspective, partly because the daily pivot level of 5342.50 could not be broken/held and the test of new ES premarket highs at 5349.25 was no longer successful during RTH, which indicates weakness in the eyes of traders. Monday’s aggressive seller was also present in ES at 5345.00, blocking the upside. ES almost hit the bottom of the trading range, and buyers were found at 5306.75 as expected. The single prints from Wednesday, May 15, have still not been filled (range bottom 5303.50), and the Friday, May 17, low of ES 5305.75 has not been broken yet. Today’s drop is healthy liquidation after a strong rally, and my own protective short did its job well.
VIX rose quickly from an 11.78 bottom to around 12.75, which is my threshold for a slightly larger dip. VIX recovered and is now at 12.35.
Nvidia results and earnings call coming up shortly.
22 Likes
Nvidia is out, the results look solid at a quick glance, and the stock price tried to nudge the $1000 level in the post-market. A split and a small dividend, gaming sector is a bit weak. Earnings call coming up soon, let’s see if this is enough for the markets.
You can easily see all of the day’s earnings releases on that site:
https://savvytrader.com/earnings
13 Likes
Nvidia pulled a swing almost the size of Finland’s GDP within 2 minutes in the after-hours:
42 Likes
And -4% on the board. Growth has no value 
1 Like
Almost normal daily volatility, quite a small move actually. By the evening, it could be something else entirely
2 Likes
Listen, dear friends! Today my portfolio hit a new ATH, surpassing the 15.11.2021 clown level, woohoo!
48 Likes
Yeah, it certainly can. I also only have a small weighting in my long-term portfolio and daily movements don’t matter at all, but it’s amusing how on the other side of the Atlantic, this stock would likely be priced differently
3 Likes
Continuing with the same pattern, YTD is now only -65% for this one. The pattern has been +10% per day for quite a while now. Maybe someone knows if it’s just a pump, or if it was just sold “too” low, now that hydrogen investments have started coming in again. Cell Impact has also woken up from its slumber.
And stopped out. I’m still learning how to use the trigger though 
E: And back in the portfolio.
It’s funny having both Wärtsilä ( 
) and Neste ( 
) in my portfolio. In 01/21, Wärtsilä cost about 8€ and Neste about 60€. Now both are around 19€. Luckily, I only bought one of them at those 2021 prices, and it wasn’t Neste.
20 Likes
What’s hit this? 
It’s only nearly 90 percent down from the offering prices..
9 Likes
People on the forum are always hyping up what great investment opportunities can be found in Sweden, but there are plenty of rotten apples there too.
They released a couple of news items this morning:
Subsidiary acquired in October filed for bankruptcy - https://fragbitegroup.com/mfn_news/fragbite-group-forsatter-dotterbolaget-fall-damage-studio-i-konkurs/
The CEO had enough and is stepping down - https://fragbitegroup.com/mfn_news/marcus-teilman-lamnar-pa-egen-begaran-uppdraget-som-vd/
And that’s not all, a “small” share issue is also on the way - https://fragbitegroup.com/mfn_news/styrelsen-i-fragbite-group-ab-beslutar-om-en-foretradesemission-om-cirka-721-msek/
https://www.redeye.se/research/1010293/fragbite-group-bad-luck-comes-in-threes
Through the rights issue of SEK72.1m, the company is issuing 3,603,812,718 new shares, corresponding to a dilution of c97.1% for existing investors. 
The subscription price is set at SEK0.02 per share, a discount of c95% against yesterday’s closing price
15 Likes
What’s the deal?
4 Likes